Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

The recent reduction of live attenuated influenza vaccine (LAIV) effectiveness in multivalent formulations was particularly associated with the A(H1N1)pdm09 component. In the 2017 the WHO vaccine composition committee changed its recommendations for the A(H1N1)pdm09 component to include an A/Michiga...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Vaccine X
Prif Awduron: Shcherbik, Svetlana, Pearce, Nicholas, Carney, Paul, Bazhenova, Ekaterina, Larionova, Natalie, Kiseleva, Irina, Rudenko, Larisa, Kumar, Amrita, Goldsmith, Cynthia S., Dugan, Vivien, Stevens, James, Wentworth, David E., Bousse, Tatiana
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2019
Pynciau:
Regular paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668239/
https://ncbi.nlm.nih.gov/pubmed/31384746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvacx.2019.100031
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg